Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study

NCT01486238 is registered in ClinicalTrials.gov with Valley Retina Institute as lead sponsor.

NCT NCT01486238
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01486238 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pegaptanib for Retinal Edema Secondary to Diabetic Vascular Disease(Preserve) Study
Lead sponsor
Valley Retina Institute
Phase
Phase 4
Overall status
Completed
Start date
April 30, 2009
Completion date
October 31, 2011
Enrollment
72 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic macular edema